Alzheimer's Disease
Alzheimer's Disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to memory loss, confusion, and changes in behavior.
TDP-43 Proteinopathies: New Imaging Agent Study
We are testing a new PET imaging agent to see if it can effectively identify TDP-43 inclusions in the brains of patients suspected of having related conditions. This study compares results with healthy individuals to assess its potential.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Familial and Sporadic Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control and eventual paralysis.
Familial and Sporadic Frontotemporal Dementia
Frontotemporal Dementia (FTD) is a group of disorders caused by progressive degeneration of the frontal and temporal lobes of the brain, affecting personality, behavior, and language.
Suspected Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE)
Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE) is a condition characterized by the accumulation of TDP-43 protein in the brain, leading to cognitive decline and memory issues, particularly in older adults.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC
Radiology and Nuclear Medicine
Amstelveen, Netherlands
Sponsor: AC Immune SA
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.